Year |
Citation |
Score |
2010 |
Wanjalla CN, Faul EJ, Gomme EA, Schnell MJ. Dendritic cells infected by recombinant rabies virus vaccine vector expressing HIV-1 Gag are immunogenic even in the presence of vector-specific immunity. Vaccine. 29: 130-40. PMID 20728525 DOI: 10.1016/J.Vaccine.2010.08.042 |
0.617 |
|
2010 |
Faul EJ, Wanjalla CN, Suthar MS, Gale M, Wirblich C, Schnell MJ. Rabies virus infection induces type I interferon production in an IPS-1 dependent manner while dendritic cell activation relies on IFNAR signaling. Plos Pathogens. 6: e1001016. PMID 20661430 DOI: 10.1371/Journal.Ppat.1001016 |
0.677 |
|
2010 |
Gomme EA, Faul EJ, Flomenberg P, McGettigan JP, Schnell MJ. Characterization of a single-cycle rabies virus-based vaccine vector. Journal of Virology. 84: 2820-31. PMID 20053743 DOI: 10.1128/Jvi.01870-09 |
0.687 |
|
2009 |
Faul EJ, Lyles DS, Schnell MJ. Interferon response and viral evasion by members of the family rhabdoviridae. Viruses. 1: 832-51. PMID 21994572 DOI: 10.3390/V1030832 |
0.665 |
|
2009 |
Faul EJ, Aye PP, Papaneri AB, Pahar B, McGettigan JP, Schiro F, Chervoneva I, Montefiori DC, Lackner AA, Schnell MJ. Rabies virus-based vaccines elicit neutralizing antibodies, poly-functional CD8+ T cell, and protect rhesus macaques from AIDS-like disease after SIV(mac251) challenge. Vaccine. 28: 299-308. PMID 19879223 DOI: 10.1016/J.Vaccine.2009.10.051 |
0.753 |
|
2009 |
Snook AE, Li P, Stafford BJ, Faul EJ, Huang L, Birbe RC, Bombonati A, Schulz S, Schnell MJ, Eisenlohr LC, Waldman SA. Lineage-specific T-cell responses to cancer mucosa antigen oppose systemic metastases without mucosal inflammatory disease. Cancer Research. 69: 3537-44. PMID 19351847 DOI: 10.1158/0008-5472.Can-08-3386 |
0.621 |
|
2009 |
Faul EJ, Lyles DS, Schnell MJ. Interferon response and viral evasion by members of the family rhabdoviridae Viruses. 1: 832-851. DOI: 10.3390/v1030832 |
0.523 |
|
2008 |
Faul EJ, Wanjalla CN, McGettigan JP, Schnell MJ. Interferon-beta expressed by a rabies virus-based HIV-1 vaccine vector serves as a molecular adjuvant and decreases pathogenicity. Virology. 382: 226-38. PMID 18945463 DOI: 10.1016/J.Virol.2008.09.019 |
0.747 |
|
Show low-probability matches. |